Hepatitis B Diagnostic Test Market Segments and Key Trends 2016-2026


Future Market Insights has announced the addition of the “Hepatitis B Diagnostic Test Market: Global Industry Analysis and Opportunity Assessment 2016-2026” report to their offering.

Global Hepatitis B

Diagnostic Test


Share, Global Trends,

Analysis, Research, Report,


Segmentation and Forecast,


Future Market Insights



Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting

services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,

technology inputs, valuable growth insights, aerial view of the competitive framework, and future market trends.

We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC.

Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, and


We have a global presence with delivery centers across India specializing in providing global research reports and country

research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India.

We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solution for

our client.

Research Capabilities

• Customized Research

• Syndicated Research

• Investment Research

• Social Media Research

Sector Coverage

• Automotive and Transportation

• Electronics, Semiconductor, and ICT

• Retail and Consumer Products

• Industrial Automation and Equipment

• Chemicals & Materials

• Food and Beverages

• Services and Utilities

• Energy, Mining, Oil, and Gas







Social Media


Subscription Information

For detailed subscription information please contact

Hari. T (Sr. Manager - Global Business Development)

T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268

Email: hari.t@futuremarketinsights.com

Report Description

Hepatitis B is an infectious disease associated with the inflammation of the liver. Hepatitis B

infection is caused due to the Hepatitis B virus (HBV) transmitted from one person to other

through infectious blood, semen and other body fluids. Hepatitis B infection can be acute and it

may develop into chronic infection if not diagnosed and treated at an early stage. Chronically

infected Hepatitis B patients eventually develop liver cirrhosis, hepatocellular carcinoma (liver

cancer), fulminant hepatitis B (autoimmune disorder) or suffer from liver failure requiring liver

transplant and can even result in death. In 2014, out of the 360 Mn people infected with

hepatitis B worldwide, around 1 Mn people died of the disease or other complications

associated with it. However, there is a significant decrease in incidence of hepatitis B after

introduction of hepatitis B vaccine. Diagnosis of HBV is achieved by performing several tests for

serological markers of HBV such as HBsAg, anti-HBs antibodies, HBeAg, anti-HBe antibodies and

anti-HBV core antibodies. Currently, nucleic acid testing for HBV DNA is used to detect the

hepatitis B viral load. The diagnosis of hepatitis B involves collection of blood samples followed

by the detection of viral antigens and antibodies in either serum or plasma.

Hepatitis B Diagnostic Test Market: Drivers and Restraints

In vitro diagnostics is the vital market for the hepatitis B diagnostic test as the serological

markers from blood are tested outside the body in the laboratory. Increasing prevalence and

incidence of hepatitis B worldwide and multitude of available tests are the major drivers for the

increasing growth of global hepatitis B diagnostic test market.

Increasing public awareness and understanding of viral hepatitis, promotion of wider access to

monitoring and screening procedures by several countries as a part of national program and

introduction of evidence based policies are anticipated to aid the growth of global hepatitis B

diagnostic tests market. However, complexity of clinical management and lack of coordination

between clinicians and laboratory personnel to decide choice of assay employing appropriate

hepatitis B diagnostic test will remain some of the major restraints for the global hepatitis B

diagnostic test market.

Request for sample report: http://www.futuremarketinsights.com/reports/sample/rep-gb-1332

Hepatitis B Diagnostic Test Market: Segmentation

The global hepatitis B diagnostic tests market is classified on the basis of test type, technique

end use and geography.

Based on test type, the global hepatitis B diagnostic test market is segmented into the following:

Hepatitis B surface antigen test (HBsAg)

Anti-hepatitis B surface antibody test

Hepatitis B core antigen test (HBcAb)

Anti-hepatitis B core antibody test

HBV DNA test


Report Description

Based on techniques, the global hepatitis B diagnostic test market is segmented into the



Report Description

Radioimmunoassay (RIA)

Enzyme-linked immunosorbent assay (ELISA)


Based on end use type, the global hepatitis B diagnostic test market is segmented into the



Diagnostic centers


Hepatitis B Diagnostic Test Market: Overview

More than 13 immunoassays are available for the diagnosis of hepatitis B at an early stage.

They can also be used to distinguish acute and chronic hepatitis B infections. Global market

for HBsAg test is expected to drive the greater revenue generation as it the preliminary test

for the detection of HBV in the blood of infected person and also the test is ordered for

many of the blood donors prior to blood donation.

Report Description

Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-1332

Hepatitis B Diagnostic Test Market: Regional Overview

Geographically, the global hepatitis B diagnostic tests market is classified into regions

namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan,

Middle East and Africa. North America is expected to be the key region in global hepatitis

diagnostic tests market followed by Asia-Pacific and Europe. Availability of good

reimbursement policies for diagnostic tests in many of the high income countries in Europe

is expected to keep up the market for hepatitis B diagnostic testsin nearest future.

Hepatitis B Diagnostic Test Market: Key Players

Some of the key players providing diagnostic tests for hepatitis B are MedMira Inc, Abbott

Laboratories, Inovio pharmaceuticals Inc., Siemens Healthcare GmbH, Innovita biological

technology Co. Ltd., Assure Tech. (Hangzhou) Co. Ltd., Nantong Diagnos biotechnology Co.

Ltd., Blue Cross Bio-Medical (Beijing) Co. Ltd., BioGenex., Abnova Corporation etc.

Thank You!

To know more about us, please visit our website:


For sales queries or new topics email us on:


Future Market Insights: 616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989, United States

T: +1-347-918-3531 | D: +1-845-579-5705

More magazines by this user
Similar magazines